ABAnne Maria Beukers

Anne Maria Beukers

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anne Maria Beukers has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Co-creating a patient-driven digital monitoring agenda for thoracic aortic disease: a multiphase qualitative study

    by Nimrat Grewal, Nora Bacour, Youness Aouragh, Aytug U Tirpan, Anne M Beukers, Simran Grewal

    Objectives: To identify, through structured co-creation with patients across the thoracic aortic disease (TAD) spectrum, which domains of between-visit monitoring patients themselves consider meaningful and to translate these into a patient-driven digital monitoring agenda. Design: Qualitative co-creation study in four sequential phases: secondary analysis of existing patient engagement material (A), targeted focus groups addressing under-represented perspectives (B), a mixed-stakeholder co-design workshop (C) and a member-check validation session (D). Analysis used reflexive thematic analysis and framework synthesis. Reported following Consolidated Criteria for Reporting Qualitative Research (COREQ). Setting: A single Dutch tertiary referral centre for TAD, 2024–2025. Participants: Adults (≥18 years) with TAD, purposively sampled across three trajectories: surgically managed acute dissection, elective aortic surgery and aneurysm or bicuspid aortic valve under surveillance. Phase A, 45 participants in six sessions; phase B, 13 in two focus groups; phase C, 9 (6 patients, 3 healthcare professionals); phase D, 9 participants from earlier phases. Outcome measures: Patient-derived domains considered relevant to digital monitoring and their translation into components of a monitoring agenda, together with the conditions participants regarded as necessary for such monitoring to be acceptable. Results: Five domains recurred across trajectories: managing uncertainty and fear of recurrence, interpreting symptoms and bodily signals, blood pressure self-monitoring and variability, life participation including activity and reproductive decisions and accessibility and proportionality. These were translated into an agenda comprising symptom contextualisation, longitudinal blood pressure trends, patient-reported outcomes, contextual activity feedback, educational decision support and transparent escalation pathways. Participants framed monitoring as an adjunct to imaging surveillance, not a replacement, emphasising interpretability and restrained alerting. Conclusion: Structured patient engagement and iterative co-design produced a patient-driven digital monitoring agenda for TAD integrating biomedical and psychosocial dimensions, describing priorities articulated by these participants rather than their distribution and providing a foundation for developing and evaluating hybrid digital surveillance models in aortic care.

  • Open Access

    In Response

    by Anne M. Beukers, Markus W. Hollmann, Susanne Eberl, Henning Hermanns

    Was not provided for this article.

  • Open Access

    Microcirculatory effects of cardiopulmonary bypass primings in coronary artery bypass graft surgery the prime randomised clinical trial for a physiological proof-of-principle

    by Anne M. Beukers, Jord C. Seegers, Nikki van Haasteren, Meike Brouwers, Ruben J. Bosch, Anita M. Tuip-De Boer, Charissa E. van Den Brom, Susanne Eberl, Floor J. Mansvelder, Gudrun Kunst, et al.

    Objectives: Cardiopulmonary bypass (CPB) impairs endothelial function, causing oedema and disturbed microcirculatory perfusion, that contribute to organ dysfunction following cardiac surgery. We hypothesised that the composition of CPB prime fluids with either albumin or gelofusine preserves sublingual microcirculatory perfusion in patients undergoing coronary artery bypass graft surgery. Methods: Thirty-four patients were subjected to CPB primed with 1500 ml of either albumin/ringers (n = 8, gelofusine/ringers ( n = 11), or solely ringers plus retrograde autologous priming (RAP) ( n = 15). All solutions included 100 ml of mannitol. The primary outcome was perfused vessel density (PVD) assessed after anaesthesia induction, aortic cross-clamping, weaning from CPB, upon intensive care unit (ICU) arrival and 24 h after ICU arrival. Results: CPB immediately impaired PVD across all groups, persisting until ICU arrival. The decrease in PVD was most profound with albumin/ringers (estimated mean difference between baseline and ICU arrival −7.56 [95% CI -11.53 to −3.59] mm . mm -2 ), compared to gelofusine/ringers (−4.10 [−7.53 to −0.67] mm . mm -2 ), and ringers/RAP (−3.77 [-6.64 to −0.90] mm . mm -2 ), without differences between groups ( p = 0.41). In patients receiving gelofusine/ringers COP was preserved after aortic cross clamping. Concentration of inflammatory (interleukin-6) and endothelial damage markers (angiopoietin-2) were increased with albumin/ringers compared with gelofusine/ringers and ringers plus RAP. Conclusion: In this exploratory physiological study, all of the three CPB priming strategies, albumin/ringers, gelofusine/ringers or ringers plus RAP, similarly induced perioperative microcirculatory dysfunction in patients undergoing CABG surgery.


  • Open Access

    Protamine dosing in cardiac surgery: method is key

    by Anne M. Beukers, Floor J. Mansvelder, Susanne Eberl, Henning Hermanns

    Protamine dosing in cardiac surgery: method is key

  • Open Access

    APECx —Anaesthesia, Perfusion and Surgical Practices in Cardiac Surgery: Main Study Protocol of a Modular Multiphase Prospective International Multicentre Observational Study

    by Jord C. Seegers, Nimrat Grewal, Relin van Vliet, Tim Berger, Bhiraj Bhatia, Crispiana Cozowicz, Martin Czerny, Jacopo D’ANdria Ursoleo, Alessandro Della Corte, Stefan Dodic, et al.

    The perioperative management in adult cardiac surgery patients remains highly variable across centres and regions. The APECx study (Anaesthesia, Perfusion and surgical practicEs in Cardiac surgery) aims to describe the incidence of key clinical patient outcomes, map global variation in anaesthesia, perfusion and surgical practices in cardiac surgery, identify potential modifiable factors associated with relevant clinical outcomes, and explore global, socioeconomic and sex‐based differences within these practices. APECx is a prospective multicentre observational study scheduled to start in 2026 that will be conducted in cardiac surgery centres worldwide. Through a modular design, the research focus will evolve over time by going through multiple study phases during a 10‐year period. Participating centres can join or leave each study phase and will be actively recruited over the course of the entire study period. Data collection will occur biannually, including all consecutive eligible cases during two prospectively pre‐specified locally defined consecutive weeks within a 3‐month window. Data will be collected using a web‐based electronic case report form. Collected data will be limited to a clearly delineated minimised dataset. All data are routinely obtained as part of standard clinical care. Overall clinical outcomes include, but are not limited to, intensive care unit (ICU) and hospital length of stay, and in‐hospital mortality with a maximum follow‐up of 30 days. A pilot study will evaluate the feasibility and quantify the workload for participating sites. This study protocol was approved by the Medical Ethics Review Committee of Amsterdam UMC and will be conducted in accordance with local regulations at each participating centre. APECx is a modular, multiphase, large‐scale, international, multicentre cohort study with the potential to contribute to standardised, evidence‐based care worldwide. By minimising site burden, APECx will allow centres with varying amounts of resources from various economies to join. The modular design uniquely positions it to provide a broad overview of global perioperative practices in cardiac surgery, while enabling detailed investigation of specific evidence gaps.

  • Open Access

    Effectiveness of Cardiopulmonary Bypass Priming with Albumin, Gelofusine and Crystalloids with Retrograde Autologous Priming in Preventing Microcirculatory Dysfunction in Patients during Coronary Artery Bypass Graft Surgery - (PRIME) a Double-Blind Randomized Trial

    by Anne M. Beukers, Jord Seegers, Nikki van Haasteren, Meike Brouwers, Ruben J. Bosch, Anita M. Tuip-De Boer, Charissa E. van Den Brom, Susanne Eberl, Gudrun Kunst, David M.P. van Meenen, et al.

    Introduction: Cardiopulmonary bypass (CPB) can cause endothelial dysfunction, leading to edema formation, disturbed microcirculatory perfusion, and impaired tissue oxygenation. Together, these factors contribute to organ dysfunction in patients undergoing cardiac surgery. We hypothesis that the composition of CPB prime fluids influences endothelial function and prevents microcirculatory dysfunction. We assessed the impact of three different CPB prime fluid strategies on microcirculatory perfusion in adult patients undergoing coronary artery bypass graft surgery. Methods: Thirty-four patients were subjected to CPB primed with 1500 mL of either albumin/ringers, gelofusine/ringers, or solely ringers plus retrograde autologous priming (RAP). All three priming solutions included 100 mL of mannitol. The primary outcome was perfused vessel density (PVD) assessed by sublingual microcirculatory imaging at 5 time points (after anesthesia induction, aortic cross-clamping, weaning from CPB, upon intensive care unit arrival (ICU), and 24 hrs after ICU arrival) as main marker of microcirculatory perfusion. Secondary outcomes included total vessel density, proportion of perfused vessels, microvascular flow-, and heterogeneity index (as additional markers of microcirculatory perfusion), colloid oncotic pressure (COP), albumin, glycocalyx shedding-, endothelial-, inflammation- and renal injury markers, hemoglobin, hematocrit, hemolysis index, transfusion volumes, fluid balance and fluid requirements. Results: CPB immediately impaired PVD across all groups (albumin/ringers estimated mean difference between baseline and arrival ICU -7.56 95% CI [-11.53 to -3.59] mm mm −2 , gelofusine/ringers -4.10 [-7.53 to -0.67] mm mm −2 , and ringers plus RAP -3.77 [-6.64 to -0.90] mm mm −2 ), persisting until ICU arrival without differences between groups. In patients receiving gelofusine/ringers COP was preserved after aortic cross clamping, and was associated with lower intraoperative fluid requirements and fluid balances compared to those receiving albumin/ringers or ringers plus RAP. Levels of inflammatory (interleukin-6) and endothelial damage markers (angiopoietin-2) were higher in patients receiving albumin/ringers compared with those receiving gelofusine/ringers, and ringers plus RAP. Conclusion: All of the three CPB priming strategies - albumin/ringers, gelofusine/ringers or ringers plus RAP – similarly induced perioperatieve microcirculatory dysfunction in patients undergoing CABG surgery. These findings suggest that none of these prime fluid strategies confers protection for microcirculatory perfusion during cardiac surgery. Albumin priming resulted in increased inflammatory markers at 24 hrs after surgery. Trial registration: ClinicalTrials.gov, NCT05647057 . Registered on 04/25/2023. ClinicalTrials.gov PRS: Record Summary NCT05647057 , all items can be found in the protocol.

  • Open Access

    Optimization of cardiopulmonary bypass prime fluid to preserve microcirculatory perfusion during on-pump coronary artery bypass graft surgery: PRIME study protocol for a double-blind randomized trial

    by Anne M. Beukers, Carolien S. E. Bulte, Ruben J. Bosch, Susanne Eberl, Charissa E. van Den Brom, Stephan A. Loer, Alexander B. A. Vonk

    Background: Acute microcirculatory perfusion disturbances and organ edema are important factors leading to organ dysfunction during cardiac surgery with cardiopulmonary bypass (CPB). Priming of the CPB system with crystalloid or colloid fluids, which inevitably leads to hemodilution, could contribute to this effect. However, there is yet no optimal evidence-based strategy for this type of priming. Hence, we will investigate different priming strategies to reduce hemodilution and preserve microcirculatory perfusion. Methods: The PRIME study is a single-center double-blind randomized trial. Patients undergoing elective coronary artery bypass graft surgery with CPB will be randomized into three groups of prime fluid strategy: (1) gelofusine with crystalloid, (2) albumin with crystalloid, or (3) crystalloid and retrograde autologous priming. We aim to include 30 patients, 10 patients in each arm. The primary outcome is the change in microcirculatory perfusion. Secondary outcomes include colloid oncotic pressure; albumin; hematocrit; electrolytes; fluid balance and requirements; transfusion rates; and endothelial-, glycocalyx-, inflammatory- and renal injury markers. Sublingual microcirculatory perfusion will be measured using non-invasive sidestream dark field video microscopy. Microcirculatory and blood measurements will be performed at five consecutive time points during surgery up to 24 h after admission to the intensive care unit. Discussion: PRIME is the first study to assess the effect of different prime fluid strategies on microcirculatory perfusion in cardiac surgery with CPB. If the results suggest that a specific crystalloid or colloid prime fluid strategy better preserves microcirculatory perfusion during on-pump cardiac surgery, the current study may help to find the optimal pump priming in cardiac surgery. Trial registration: ClinicalTrials.gov NCT05647057. Registered on 04/25/2023. ClinicalTrials.gov PRS: Record Summary NCT05647057, all items can be found in the protocol.


  • Open Access

    Changes in colloid oncotic pressure during cardiac surgery with different prime fluid strategies

    by Anne Maria Beukers, Juan de Villiers Hugo, Renard Gerardus Haumann, Jan Willem Taco Boltje, Evy Loan Khiam Ie, Stephan Alexander Loer, Carolien Suzanna Enna Bulte, Alexander Vonk

    Objective: In cardiac surgery, colloid oncotic pressure (COP) is affected by haemodilution that results from composition and volume of prime fluid of cardiopulmonary bypass (CPB). However, the extent to which different priming strategies alter COP is largely unknown. Therefore, we investigated the effect of different priming strategies on COP in on-pump cardiac surgery. Methods: Patients ( n = 60) were divided into 3 groups ( n = 20 each), based on the center in which they were operated and the specific prime fluid strategy used in that center during the inclusion period. CPB prime fluids were either gelofusine-, albumin-, or crystalloid based, the latter two with or without retrograde autologous priming. Results: In all groups, COP was lowest after weaning from CPB and one hour after CPB. Between groups, COP was lowest with gelofusine prime fluid (16.4, 16.8 mmHg, respectively) compared with crystalloids (MD: -1.9; 95% CI:-3.6, -0.2; p = .02 and MD: -2.4, 95% CI: -4.2, -0.7; p = .002) and albumin (MD: -1.8, 95% CI: -3.5, -0.50; p = .041 and MD: -2.4, 95% CI: -4.1, -0.7; p = .002). In all groups, the decrease in COP one hour after bypass compared to baseline correlated positively with fluid balance at the end of surgery ( p < .001). Conclusions: COP significantly decrease during CPB surgery with the largest decrease in COP at the end of surgery, while at the same time fluid balance increases. We suggest that prime fluid strategy should be carefully selected when maintenance of COP during cardiac surgery is desirable.


  • Open Access

    Effects of crystalloid and colloid priming strategies for cardiopulmonary bypass on colloid oncotic pressure and haemostasis: a meta-analysis

    by Anne Maria Beukers, Jamy Adriana Catharina de Ruijter, Stephan Alexander Loer, Alexander Vonk, Carolien Suzanna Enna Bulte

    Colloid oncotic pressure (COP) is an important factor in cardiac surgery, owing to its role in haemodilution. The effect of cardiopulmonary bypass prime fluids on the COP is unknown. In this study, the effect of crystalloid and colloid prime fluids, with or without retrograde autologous priming (RAP), on the COP during elective cardiac surgery was evaluated. Randomized controlled trials and prospective clinical trials comparing crystalloid and colloid priming fluids or with RAP were selected. The primary outcome was the COP; secondary outcomes were fluid balance, fluid requirements, weight gain, blood loss, platelet count and transfusion requirements. From 1582 records, 29 eligible studies were identified. COPs were comparable between gelofusine and hydroxyethyl starch (HES) during bypass [mean difference (MD): 0.69; 95% confidence interval (CI): −2.05, 3.43; P = 0.621], after bypass (MD: −0.11; 95% CI: −2.54, 2.32; P = 0.930) and postoperative (MD: −0.61; 95% CI: −1.60, 0.38; P = 0.228). Fluid balance was lower with HES than with crystalloids. RAP reduced transfusion requirements compared with crystalloids. Blood loss was comparable between groups. COPs did not differ between crystalloids and colloids. As a result of increased transcapillary fluid movement, fluid balance was lower with HES than with crystalloids. Haematocrit and transfusion requirements were comparable between groups. However, the latter was lower when RAP was applied to crystalloid priming compared with crystalloids alone. Finally, no differences in blood loss were observed between the groups.